Clostridium difficile infection associated with bismuth-based quadruple therapy (Pylere®) for Helicobacter pylori eradication

被引：3
|
作者：
Castro-Fernandez, Manuel [1 ]
Marques-Ruiz, Alberto [1 ]
Camara-Baena, Sergio [1 ]
Grande-Santamaria, Lourdes [1 ]
机构：
[1] Hosp Univ Valme, Unidad Gest Cin Enfermedades Digest, Seville, Spain
来源：
GASTROENTEROLOGIA Y HEPATOLOGIA | 2019年 / 42卷 / 07期
关键词：
TRIPLE-THERAPY; CLARITHROMYCIN; METRONIDAZOLE;
D O I：
10.1016/j.gastrohep.2019.01.012
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：459 / 460
页数：2
相关论文
共 50 条
  • [21] Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies
    Graham, David Y.
    Dore, Maria Pina
    Lu, Hong
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2018, 16 (09) : 679 - 687
  • [22] Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication
    Lee, Jung Won
    Kim, Nayoung
    Nam, Ryoung Hee
    Lee, Sun Min
    Soo In, Choi
    Kim, Jung Mogg
    Lee, Dong Ho
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (04) : 666 - 672
  • [23] Furazolidone, amoxicillin, bismuth and rabeprazole quadruple rescue therapy for the eradication of Helicobacter pylori
    Cheng, Hong
    Hu, Fu-Lian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (07) : 860 - 864
  • [24] Letter: bismuth quadruple therapy with Pylera for Helicobacter pylori infection - authors' reply
    Malfertheiner, P.
    Delchier, J. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (06) : 736 - 737
  • [25] A randomized clinical trial comparing triple therapy versus non-bismuth based quadruple therapy for the eradication of Helicobacter Pylori in Kuwait
    Alfadhli, Ahmad
    Alboraie, Mohamed
    Afifi, Mostafa
    Dangi, Abhijit
    JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2022, 14 (03) : 99 - +
  • [26] Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy
    Chen, Qi
    Zhang, Wei
    Fu, Qingyan
    Liang, Xiao
    Liu, Wenzhong
    Xiao, Shudong
    Lu, Hong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (12) : 1736 - 1742
  • [27] Comparison of tailored Helicobacter pylori eradication versus modified bismuth quadruple therapy in Korea: a randomized controlled trial
    Cho, Jun-Hyung
    Jin, So Young
    Park, Suyeon
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (06) : 923 - 929
  • [28] Evaluation of safety and pharmacokinetics of bismuth-containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication
    Huh, Ki Young
    Chung, Hyewon
    Kim, Yu Kyong
    Lee, SeungHwan
    Bhatia, Siddharth
    Takanami, Yohei
    Nakaya, Ryou
    Yu, Kyung-Sang
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (01) : 138 - 144
  • [29] Bismuth-based Quadruple Therapy Following H. pylori Eradication Failures: a Multicenter Study in Clinical Practice
    Zullo, Angelo
    De Francesco, Vincenzo
    Bellesia, Annamaria
    Vassallo, Roberto
    D'Angelo, Audenzio
    Scaccianoce, Giuseppe
    Sacco, Rodolfo
    Bresci, Giampaolo
    Eramo, Annarita
    Tanzilli, Anna
    Ridola, Lorenzo
    Alvaro, Domenico
    London, Claudio
    Brambilla, Gianfranco
    Manta, Raffaele
    Di Ciaula, Agostino
    Portincasa, Piero
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2017, 26 (03) : 225 - 229
  • [30] A novel therapeutic approach for Helicobacter pylori infection:: the bismuth-based triple therapy monocapsule
    de Boer, WA
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (08) : 1559 - 1566
12345